CBD (cannabidiol), an important cannabinoid component of the cannabis plant, is a pharmacologically broad-spectrum drug that has attracted increasing attention in recent years as a treatment for a range of neuropsychiatric disorders. The potential of CBD as a treatment for depression-related disorders was determined by evaluating evidence from preclinical, human, clinical, and epidemiological studies. The […]